Antibody Conjugate Therapeutics: Challenge and Potential
Antibody conjugates are a diverse class of therapeutics consisting of a cytotoxic agent linked covalently to an antibody or antibody fragment directed toward a specific cell surface target expressed by tumor cells. The notion that antibodies directed toward targets on the surface of malignant cells could be used for drug delivery is not new.
- Antibody-Drug Conjugates Design And Development
- Bispecific antibody conjugates in therapeutics
- Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
- New Developments in Antibody-Drug Conjugates
Related Conference of Antibody Conjugate Therapeutics: Challenge and Potential
April 14-15, 2025
12th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Paris, France
July 24-25, 2025
20th International Conference on Allergic Diseases and Clinical Immunology
Paris, France
August 26-27, 2025
6th International conference on Vaccines, Vaccination and Immunization
Paris, France
Antibody Conjugate Therapeutics: Challenge and Potential Conference Speakers
Recommended Sessions
- Anti-Cancer Antibodies
- Antibiotics
- Antibiotics used in Industries
- Antibiotics: Advances in Treatment
- Antibiotics: Applications
- Antibiotics: Clinical Trials
- Antibiotics: Infectious Diseases
- Antibiotics: Mechanism of Action
- Antibodies: Infectious Diseases
- Antibodies: Medical Applications
- Antibody Conjugate Therapeutics: Challenge and Potential
- Antibody Drug Therapy
- Antibody Engineering
- Antibody Humanization Technologies
- Auto Immune Antibodies
- Bio therapeutics : Early Analytical Development
- Bio Therapeutics: Novel Formulation and Delivery Approaches
- Cancer Immune therapy
- Emerging Protein Bio Therapeutics
- Immunotherapy and Immune Checkpoints
- Monoclonal Antibody Therapy
- Next-Generation Sequencing(NGS) in Antibody Discovery and Engineering: Overview and Applications
- Protein Engineering and Genetic Engineering
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibiotic Prophylaxis - Antibiotics 2025 (France)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2025 (France)
- Antibiotic-resistant Bacterial infections - Antibiotics 2025 (France)
- Antibiotics - Antibiotics 2025 (France)
- Antibiotics for Various Diseases and Infections - Antibiotics 2025 (France)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2025 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Antimicrobial Peptides - Antibiotics 2025 (France)
- Antimicrobial Therapy - Antibiotics 2025 (France)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Italy)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Italy)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Italy)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Clinical Trials of Antibiotics - Antibiotics 2025 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- Current research in antibiotic resistance - Antibiotics 2025 (France)
- Developing Alternatives to Antibiotics - Antibiotics 2025 (France)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (France)
- Different Types of Antibiotics - Antibiotics 2025 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2025 (France)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Italy)
- Epidemiology - European Immunology 2025 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immune System - European Immunology 2025 (France)
- Immunodeficiency - European Immunology 2025 (France)
- Immunogenetics - European Immunology 2025 (France)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (France)
- Immunological Techniques - European Immunology 2025 (France)
- Immunology - European Immunology 2025 (France)
- Immunology & Vaccines - Antibiotics 2025 (France)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Italy)
- Immunotherapy - European Immunology 2025 (France)
- Immunotoxicology - European Immunology 2025 (France)
- Infectious Diseases - Antibiotics 2025 (France)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Italy)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics 2025 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2025 (France)
- Microorganisms Producing Antibiotics - Antibiotics 2025 (France)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Italy)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology - European Immunology 2025 (France)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Italy)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Italy)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Italy)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Italy)
- Parasite Immunology - European Immunology 2025 (France)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Pediatrics Immunology - European Immunology 2025 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2025 (France)
- Pharmacology & Toxicology - Antibiotics 2025 (France)
- Reproductive Immunology - European Immunology 2025 (France)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Italy)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Italy)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2025 (France)
- Transplantation Immunology - European Immunology 2025 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)
- Viral Immunology - European Immunology 2025 (France)